Developer docs
API playgroundTry for free, no card

Search company profiles

Phases

Full company profile

uuid00023mi

Namestring
Phases
Legal namestring
Phases Innovations Inc.
Websiteurl
phases.ai
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Phases (Phases Innovations Inc.) is a San Francisco-based B2B SaaS company that deploys AI agents to monitor and oversee clinical trials. Its platform reads across the standard clinical trial technology stack — Electronic Data Capture (EDC), Trial Master File (TMF/CTMS), Interactive Response Technology (IRT), and electronic Trial Master File (eTMF) systems — to identify risks, surface protocol deviations, and autonomously take corrective actions such as filing documents, raising queries, escalating findings, and emailing clinical sites. A human-in-the-loop approval model governs critical actions. The core product is complemented by an Email Agent add-on that integrates with Google Workspace to automate clinical-operations email workflows.

The company targets large pharmaceutical companies and clinical trial sponsors or contract research organizations (CROs) running Phase I–IV studies, positioning itself against manual monitoring and audit-preparation bottlenecks. Self-reported technical metrics include 94% time reduction in monitoring visit report review versus human teams, 98%+ detection accuracy for emerging risks, and 97% TMF filing completeness (957/989 documents) on a cited case study. The platform is designed to meet HIPAA, GDPR, 21 CFR Part 11, and ICH GCP requirements, with a SOC 2 Type II audit in progress.

Phases operates an enterprise field-sales go-to-market with a 'Book a demo' conversion path, suggesting quote-based annual subscriptions. The company was founded in 2025, has 1–10 employees, and has disclosed a single $500,000 seed round (September 2025) led by Y Combinator with participation from SAV (Scale Asia Ventures) and u.ventures. Leadership comprises CEO James Wall, Chief AI Officer Anton Zaliznyi, and CTO Jonathan Wersch. No customer logos, revenue figures, or M&A activity are disclosed.

Short descriptiontext

Phases is a San Francisco-based SaaS company that deploys AI agents to monitor clinical trials across EDC, TMF, CTMS, IRT, and eTMF systems, serving pharmaceutical companies and CROs with enterprise subscriptions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial oversight, AI clinical operations, trial management software, regulatory compliance software, pharmaceutical data analytics
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Clinical Trial Oversight Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription
TypeSubscription Recurring
Description

Phases operates as a B2B SaaS platform providing AI-powered clinical trial oversight services on a subscription basis to pharmaceutical companies and clinical trial sponsors.

phases.ai
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise subscription pricing - custom quote
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

phases.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Phases provides an AI-powered clinical trial oversight platform that deploys autonomous AI agents to continuously monitor Electronic Data Capture (EDC), Trial Master File (TMF), Clinical Trial Management System (CTMS), Interactive Response Technology (IRT), and electronic TMF systems. The agents review 100% of monitoring visit reports, detect risks with 98%+ accuracy, file and QC regulatory documents, and take corrective actions (query raising, escalation, site communications) under a human-in-the-loop approval model, targeting pharmaceutical companies and CROs running Phase I–IV trials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 94% time reduction in monitoring report review vs human teams
+3 more records
Product overview1 text field

Phases offers a unified AI-powered clinical trial oversight platform. The core product deploys AI agents that continuously monitor clinical trials by reading across EDC, TMF, CTMS, and eTMF systems, identifying risks, and autonomously taking corrective actions such as filing documents, raising queries, and escalating issues. The platform is complemented by an Email Agent add-on module that provides AI-powered email automation through Google Workspace integration, enabling automated email composition, categorization, and sending for clinical site communication.

Product and service1 record
1Phases Clinical Trial Oversight Platform
CategoryClinical Trial Oversight Software
Description

AI-powered clinical trial oversight platform that deploys autonomous agents to monitor, analyze, and take action across EDC, TMF, CTMS, IRT, and eTMF systems. Reviews 100% of monitoring visit reports (94% time reduction vs human teams) with 98%+ risk detection accuracy, files and QC's the Trial Master File automatically, raises queries, escalates risks, and sends communications under a human-in-the-loop approval model. Built for pharmaceutical companies and CROs running Phase I–IV multi-site trials, compliant with HIPAA, GDPR, SOC 2 Type II, 21 CFR Part 11, and ICH GCP.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1EDC Systems
Strategic tierCoreTypeTechnology or Integration
Description

Phases integrates with Electronic Data Capture (EDC) systems as part of its AI trial oversight platform, reading across EDC data to identify risks and issues in real-time.

phases.ai
Strategic tierCoreTypeTechnology or Integration
Description

Phases integrates with Trial Master File systems, automatically filing, QC'ing, and maintaining inspection-ready documentation.

Strategic tierCoreTypeTechnology or Integration
Description

Phases connects with Clinical Trial Management Systems to aggregate operational data for comprehensive trial oversight.

Strategic tierCoreTypeTechnology or Integration
Description

Phases integrates with Interactive Response Technology systems for randomization and trial supply management oversight.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phases

Clinical Trial Oversight Softwarephases.ai

Phases is a San Francisco-based SaaS company that deploys AI agents to monitor clinical trials across EDC, TMF, CTMS, IRT, and eTMF systems, serving pharmaceutical companies and CROs with enterprise subscriptions.

What Phases does

Phases (Phases Innovations Inc.) is a San Francisco-based B2B SaaS company that deploys AI agents to monitor and oversee clinical trials. Its platform reads across the standard clinical trial technology stack — Electronic Data Capture (EDC), Trial Master File (TMF/CTMS), Interactive Response Technology (IRT), and electronic Trial Master File (eTMF) systems — to identify risks, surface protocol deviations, and autonomously take corrective actions such as filing documents, raising queries, escalating findings, and emailing clinical sites. A human-in-the-loop approval model governs critical actions. The core product is complemented by an Email Agent add-on that integrates with Google Workspace to automate clinical-operations email workflows.

The company targets large pharmaceutical companies and clinical trial sponsors or contract research organizations (CROs) running Phase I–IV studies, positioning itself against manual monitoring and audit-preparation bottlenecks. Self-reported technical metrics include 94% time reduction in monitoring visit report review versus human teams, 98%+ detection accuracy for emerging risks, and 97% TMF filing completeness (957/989 documents) on a cited case study. The platform is designed to meet HIPAA, GDPR, 21 CFR Part 11, and ICH GCP requirements, with a SOC 2 Type II audit in progress.

Phases operates an enterprise field-sales go-to-market with a 'Book a demo' conversion path, suggesting quote-based annual subscriptions. The company was founded in 2025, has 1–10 employees, and has disclosed a single $500,000 seed round (September 2025) led by Y Combinator with participation from SAV (Scale Asia Ventures) and u.ventures. Leadership comprises CEO James Wall, Chief AI Officer Anton Zaliznyi, and CTO Jonathan Wersch. No customer logos, revenue figures, or M&A activity are disclosed.

Phases firmographics

Firmographics
Name
Phases
Legal name
Phases Innovations Inc.
Website
https://phases.ai
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Phases is a San Francisco-based SaaS company that deploys AI agents to monitor clinical trials across EDC, TMF, CTMS, IRT, and eTMF systems, serving pharmaceutical companies and CROs with enterprise subscriptions.
Ownership category
akta.pro rank

Where Phases is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Phases business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Subscription: Phases operates as a B2B SaaS platform providing AI-powered clinical trial oversight services on a subscription basis to pharmaceutical companies and clinical trial sponsors.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription pricing - custom quote

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Phases product offering

Product offering

Core offering

Phases provides an AI-powered clinical trial oversight platform that deploys autonomous AI agents to continuously monitor Electronic Data Capture (EDC), Trial Master File (TMF), Clinical Trial Management System (CTMS), Interactive Response Technology (IRT), and electronic TMF systems. The agents review 100% of monitoring visit reports, detect risks with 98%+ accuracy, file and QC regulatory documents, and take corrective actions (query raising, escalation, site communications) under a human-in-the-loop approval model, targeting pharmaceutical companies and CROs running Phase I–IV trials.

Product overview

Phases offers a unified AI-powered clinical trial oversight platform. The core product deploys AI agents that continuously monitor clinical trials by reading across EDC, TMF, CTMS, and eTMF systems, identifying risks, and autonomously taking corrective actions such as filing documents, raising queries, and escalating issues. The platform is complemented by an Email Agent add-on module that provides AI-powered email automation through Google Workspace integration, enabling automated email composition, categorization, and sending for clinical site communication.

Differentiator

Problem solved

Functional benefit

Products and services

  • Phases Clinical Trial Oversight Platform AI-powered clinical trial oversight platform that deploys autonomous agents to monitor, analyze, and take action across EDC, TMF, CTMS, IRT, and eTMF systems. Reviews 100% of monitoring visit reports (94% time reduction vs human teams) with 98%+ risk detection accuracy, files and QC's the Trial Master File automatically, raises queries, escalates risks, and sends communications under a human-in-the-loop approval model. Built for pharmaceutical companies and CROs running Phase I–IV multi-site trials, compliant with HIPAA, GDPR, SOC 2 Type II, 21 CFR Part 11, and ICH GCP.

Quantifiable outcome

  • 94% time reduction in monitoring report review vs human teams
  • +3 more outcomes

Companies that use Phases

Customer profile

Segments2 records

Ideal customer profiles2 records

Phases technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability6 records

Feature4 records

Phases partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • EDC SystemscoreTechnology or IntegrationPhases integrates with Electronic Data Capture (EDC) systems as part of its AI trial oversight platform, reading across EDC data to identify risks and issues in real-time.
  • TMF SystemscoreTechnology or IntegrationPhases integrates with Trial Master File systems, automatically filing, QC'ing, and maintaining inspection-ready documentation.
  • CTMS PlatformscoreTechnology or IntegrationPhases connects with Clinical Trial Management Systems to aggregate operational data for comprehensive trial oversight.
  • IRT SystemscoreTechnology or IntegrationPhases integrates with Interactive Response Technology systems for randomization and trial supply management oversight.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Phases competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key highlights6 records

Customer concentration

Phases social profiles

Digital presence

Phases compliance and trust

Trust signal

Compliance5 records

Phases financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phases leadership team

Management profile

Number of profiles

Profiles3 records

Phases funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phases M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phases

What does Phases do?

Phases provides an AI-powered clinical trial oversight platform that deploys autonomous AI agents to continuously monitor Electronic Data Capture (EDC), Trial Master File (TMF), Clinical Trial Management System (CTMS), Interactive Response Technology (IRT), and electronic TMF systems. The agents review 100% of monitoring visit reports, detect risks with 98%+ accuracy, file and QC regulatory documents, and take corrective actions (query raising, escalation, site communications) under a human-in-the-loop approval model, targeting pharmaceutical companies and CROs running Phase I–IV trials.

Is Phases a public or private company?

Phases is a private company. It is classified as venture growth investor backed and is currently operating.

When was Phases founded?

Phases was founded in 2025. It employs 1 to 10 people.

Where is Phases based?

Phases is headquartered in San Francisco, United States, in the North America region.

How does Phases make money?

One revenue line is on record: saaS Subscription.

Does Phases have an API?

No public API is recorded for Phases.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales